# Black Hills Corp: financial statements, quarterly

BKH · NYSE · CIK 1130464 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkh.md) · [Financials](/companies/bkh/financials.md) · [Filings](/companies/bkh/filings.md) · [Insiders](/companies/bkh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bkh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [400](/filings/0000950170-24-122969.md) | [584 d](/filings/0001193125-26-046028.md) | [717](/filings/0000950170-25-066572.md) | [397](/filings/0000950170-25-100667.md) | [399](/filings/0001193125-25-268567.md) | [585 d](/filings/0001193125-26-046028.md) | [800](/filings/0001193125-26-211037.md) | [436](/filings/0001193125-26-337444.md) | [427](/filings/0001193125-25-268567.md) | [623 d](/filings/0001193125-26-046028.md) | [762](/filings/0001193125-26-211037.md) | [441](/filings/0001193125-26-337444.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [97.8](/filings/0000950170-24-122969.md) | [137 d](/filings/0001193125-26-046028.md) | [193](/filings/0000950170-25-066572.md) | [70.6](/filings/0000950170-25-100667.md) | [75.8](/filings/0001193125-25-268567.md) | [163 d](/filings/0001193125-26-046028.md) | [205](/filings/0001193125-26-211037.md) | [82.5](/filings/0001193125-26-337444.md) | [78.7](/filings/0001193125-25-268567.md) | [171 d](/filings/0001193125-26-046028.md) | [202](/filings/0001193125-26-211037.md) | [97.0](/filings/0001193125-26-337444.md) |
| Interest expense | $m | not reported | not reported | [44.0](/filings/0000950170-25-066572.md) | [42.6](/filings/0000950170-25-100667.md) | [45.2](/filings/0001193125-25-268567.md) | [49.8 d](/filings/0001193125-26-046028.md) | [51.3](/filings/0001193125-26-211037.md) | [48.9](/filings/0001193125-26-337444.md) | [49.4](/filings/0001193125-25-268567.md) | [50.5 d](/filings/0001193125-26-046028.md) | [51.9](/filings/0001193125-26-211037.md) | [51.6](/filings/0001193125-26-337444.md) |
| Income tax | $m | [7.4](/filings/0000950170-24-122969.md) | [9.6 d](/filings/0001193125-26-046028.md) | [16.9](/filings/0000950170-25-066572.md) | [3.7](/filings/0000950170-25-100667.md) | [2.9](/filings/0001193125-25-268567.md) | [12.7 d](/filings/0001193125-26-046028.md) | [18.1](/filings/0001193125-26-211037.md) | [4.4](/filings/0001193125-26-337444.md) | [4.0](/filings/0001193125-25-268567.md) | [17.2 d](/filings/0001193125-26-046028.md) | [17.6](/filings/0001193125-26-211037.md) | [5.2](/filings/0001193125-26-337444.md) |
| Net income | $m | [45.4](/filings/0000950170-24-122969.md) | [79.7 d](/filings/0001193125-26-046028.md) | [128](/filings/0000950170-25-066572.md) | [22.8](/filings/0000950170-25-100667.md) | [24.4](/filings/0001193125-25-268567.md) | [98.1 d](/filings/0001193125-26-046028.md) | [134](/filings/0001193125-26-211037.md) | [27.5](/filings/0001193125-26-337444.md) | [24.9](/filings/0001193125-25-268567.md) | [105 d](/filings/0001193125-26-046028.md) | [131](/filings/0001193125-26-211037.md) | [38.2](/filings/0001193125-26-337444.md) |
| Diluted EPS | $ per share | [0.67](/filings/0000950170-24-122969.md) | not reported | [1.87](/filings/0000950170-25-066572.md) | [0.33](/filings/0000950170-25-100667.md) | [0.35](/filings/0001193125-25-268567.md) | not reported | [1.87](/filings/0001193125-26-211037.md) | [0.38](/filings/0001193125-26-337444.md) | [0.34](/filings/0001193125-25-268567.md) | not reported | [1.73](/filings/0001193125-26-211037.md) | [0.50](/filings/0001193125-26-337444.md) |
| Basic EPS | $ per share | [0.67](/filings/0000950170-24-122969.md) | not reported | [1.88](/filings/0000950170-25-066572.md) | [0.33](/filings/0000950170-25-100667.md) | [0.35](/filings/0001193125-25-268567.md) | not reported | [1.87](/filings/0001193125-26-211037.md) | [0.38](/filings/0001193125-26-337444.md) | [0.34](/filings/0001193125-25-268567.md) | not reported | [1.74](/filings/0001193125-26-211037.md) | [0.50](/filings/0001193125-26-337444.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0000950170-23-057904.md) | [0.1](/filings/0000950170-25-018647.md) | [0.1](/filings/0000950170-24-056459.md) | [0.6](/filings/0000950170-24-089042.md) | [0.0](/filings/0000950170-24-122969.md) | [0.0](/filings/0001193125-26-046028.md) | [0.0](/filings/0000950170-25-066572.md) | [0.0](/filings/0000950170-25-100667.md) | [0.0](/filings/0001193125-25-268567.md) | [0.2](/filings/0001193125-26-337444.md) | [0.0](/filings/0001193125-26-211037.md) | [0.1](/filings/0001193125-26-337444.md) |
| Current assets | $bn | [1.2](/filings/0000950170-23-057904.md) | [0.8](/filings/0000950170-25-018647.md) | [0.8](/filings/0000950170-24-056459.md) | [1.2](/filings/0000950170-24-089042.md) | [0.6](/filings/0000950170-24-122969.md) | [0.7](/filings/0001193125-26-046028.md) | [0.7](/filings/0000950170-25-066572.md) | [0.6](/filings/0000950170-25-100667.md) | [0.7](/filings/0001193125-25-268567.md) | [1.0](/filings/0001193125-26-337444.md) | [0.8](/filings/0001193125-26-211037.md) | [0.7](/filings/0001193125-26-337444.md) |
| Total assets | $bn | [9.9](/filings/0000950170-23-057904.md) | [9.6](/filings/0000950170-25-018647.md) | [9.7](/filings/0000950170-24-056459.md) | [10.2](/filings/0000950170-24-089042.md) | [9.7](/filings/0000950170-24-122969.md) | [10.0](/filings/0001193125-26-046028.md) | [10.1](/filings/0000950170-25-066572.md) | [10.1](/filings/0000950170-25-100667.md) | [10.3](/filings/0001193125-25-268567.md) | [10.9](/filings/0001193125-26-337444.md) | [10.8](/filings/0001193125-26-211037.md) | [11.0](/filings/0001193125-26-337444.md) |
| Current liabilities | $bn | [1.6](/filings/0000950170-23-057904.md) | [1.2](/filings/0000950170-25-018647.md) | [1.1](/filings/0000950170-24-056459.md) | [1.1](/filings/0000950170-24-089042.md) | [0.5](/filings/0000950170-24-122969.md) | [0.8](/filings/0001193125-26-046028.md) | [0.9](/filings/0000950170-25-066572.md) | [1.0](/filings/0000950170-25-100667.md) | [0.7](/filings/0001193125-25-268567.md) | [0.7](/filings/0001193125-26-337444.md) | [1.2](/filings/0001193125-26-211037.md) | [1.4](/filings/0001193125-26-337444.md) |
| Long-term debt | $bn | [3.8](/filings/0000950170-23-057904.md) | [3.8](/filings/0000950170-25-018647.md) | [3.8](/filings/0000950170-24-056459.md) | [4.2](/filings/0000950170-24-089042.md) | [4.2](/filings/0000950170-24-122969.md) | [4.3](/filings/0001193125-26-046028.md) | [4.0](/filings/0000950170-25-066572.md) | [4.0](/filings/0000950170-25-100667.md) | [4.3](/filings/0001193125-25-268567.md) | [4.7](/filings/0001193125-26-337444.md) | [4.0](/filings/0001193125-26-211037.md) | [4.0](/filings/0001193125-26-337444.md) |
| Current portion of debt | $bn | [1.1](/filings/0000950170-23-057904.md) | [0.6](/filings/0000950170-25-018647.md) | [0.6](/filings/0000950170-24-056459.md) | [0.6](/filings/0000950170-24-089042.md) | [0.0](/filings/0000950170-24-122969.md) | [0.0](/filings/0001193125-26-046028.md) | [0.3](/filings/0000950170-25-066572.md) | [0.3](/filings/0000950170-25-100667.md) | not reported | [0.0](/filings/0001193125-26-337444.md) | [0.4](/filings/0001193125-26-211037.md) | [0.4](/filings/0001193125-26-337444.md) |
| Short-term borrowings | $bn | [0.0](/filings/0000950170-23-057904.md) | [0.0](/filings/0000950170-25-018647.md) | [0.0](/filings/0000950170-24-056459.md) | [0.0](/filings/0000950170-24-089042.md) | [0.0](/filings/0000950170-24-122969.md) | [0.1](/filings/0001193125-26-046028.md) | [0.1](/filings/0000950170-25-066572.md) | [0.1](/filings/0000950170-25-100667.md) | [0.1](/filings/0001193125-25-268567.md) | [0.0](/filings/0001193125-26-337444.md) | [0.3](/filings/0001193125-26-211037.md) | [0.1](/filings/0001193125-26-337444.md) |
| Shareholders' equity | $bn | [3.2](/filings/0000950170-23-057904.md) | [3.2](/filings/0000950170-25-018647.md) | [3.3](/filings/0000950170-24-056459.md) | [3.4](/filings/0000950170-24-089042.md) | [3.4](/filings/0000950170-24-122969.md) | [3.5](/filings/0001193125-26-046028.md) | [3.6](/filings/0000950170-25-066572.md) | [3.6](/filings/0000950170-25-100667.md) | [3.8](/filings/0001193125-25-268567.md) | [3.8](/filings/0001193125-26-337444.md) | [3.9](/filings/0001193125-26-211037.md) | [3.9](/filings/0001193125-26-337444.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [151 d](/filings/0000950170-24-122969.md) | [188 d](/filings/0001193125-26-046028.md) | [233](/filings/0000950170-25-066572.md) | [231 d](/filings/0000950170-25-100667.md) | [102 d](/filings/0001193125-25-268567.md) | [153 d](/filings/0001193125-26-046028.md) | [228](/filings/0001193125-26-211037.md) | [189 d](/filings/0001193125-26-337444.md) | [88.9 d](/filings/0001193125-25-268567.md) | [168 d](/filings/0001193125-26-046028.md) | [176](/filings/0001193125-26-211037.md) | [195 d](/filings/0001193125-26-337444.md) |
| Capital expenditure | $m | [160 d](/filings/0000950170-24-122969.md) | [134 d](/filings/0001193125-26-046028.md) | [176](/filings/0000950170-25-066572.md) | [166 d](/filings/0000950170-25-100667.md) | [188 d](/filings/0001193125-25-268567.md) | [214 d](/filings/0001193125-26-046028.md) | [153](/filings/0001193125-26-211037.md) | [219 d](/filings/0001193125-26-337444.md) | [178 d](/filings/0001193125-25-268567.md) | [270 d](/filings/0001193125-26-046028.md) | [267](/filings/0001193125-26-211037.md) | [218 d](/filings/0001193125-26-337444.md) |
| Dividends paid | $m | [42.3 d](/filings/0000950170-24-122969.md) | [42.7 d](/filings/0001193125-26-046028.md) | [44.4](/filings/0000950170-25-066572.md) | [44.9 d](/filings/0000950170-25-100667.md) | [46.5 d](/filings/0001193125-25-268567.md) | [46.5 d](/filings/0001193125-26-046028.md) | [48.6](/filings/0001193125-26-211037.md) | [49.0 d](/filings/0001193125-26-337444.md) | [49.2 d](/filings/0001193125-25-268567.md) | [51.1 d](/filings/0001193125-26-046028.md) | [53.1](/filings/0001193125-26-211037.md) | [53.5 d](/filings/0001193125-26-337444.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.1](/filings/0000950170-23-057904.md) | [66.1](/filings/0000950170-24-056459.md) | [66.7](/filings/0000950170-24-089042.md) | [67.4](/filings/0000950170-24-122969.md) | [68.3](/filings/0000950170-25-066572.md) | [69.0](/filings/0000950170-25-100667.md) | [70.6](/filings/0001193125-25-268567.md) | [71.8](/filings/0001193125-26-211037.md) | [72.4](/filings/0001193125-26-337444.md) | [72.9](/filings/0001193125-25-268567.md) | [75.6](/filings/0001193125-26-211037.md) | [76.1](/filings/0001193125-26-337444.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 76,253,141 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337444.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.